Tokyo - Delayed Quote JPY

Nippon Kayaku Co., Ltd. (4272.T)

1,368.00
+12.00
+(0.88%)
At close: 3:30:00 PM GMT+9

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.
NameTitlePayExercisedYear Born
Mr. Atsuhiro Wakumoto Chairman & President 111M -- 1957
Mr. Tsutomu Kawamura General Manager of Finance & Accounting Division -- -- --
Akihiko Miura General Manager of Responsible Care & Technology Division -- -- --
Ichio Kohinata General Manager of Legal Affairs Division -- -- --
Makoto Takeda MD & Director -- -- 1964
Mr. Yoshitsugu Ishida Representative Executive Vice President & Director -- -- 1958
Shigeyuki Kawamura MD, Head of Safety Systems Group & Director -- -- 1963
Shinji Inoue MD & Director -- -- 1966
Hiroshi Shimada MD, Head of Pharmaceuticals Group & Director -- -- 1965
Yasuhito Kato MD & Executive Director -- -- --

Nippon Kayaku Co., Ltd.

Meiji Yasuda Seimei Building
19th and 20th Floors 1-1, Marunouchi 2-chome Chiyoda-ku
Tokyo, 100-0005
Japan
81 3 6731 5200 https://www.nipponkayaku.co.jp
Industry: 
Chemicals
Full Time Employees: 
5,902

Description

Nippon Kayaku Co., Ltd., together with its subsidiaries, develops, manufactures, and sells functional chemicals, pharmaceuticals, safety systems, and agrochemicals and other products in Japan and internationally. The company's Functional and Chemical Business segment offers functional materials, such as epoxy resins, maleimide resins, UV-curable resins, sealants for LCD and LED, maleimide resins, photoresists and insulating materials for micro electro mechanical systems, and cleaning agents and chemicals. This segment provides color materials, including inkjet colorants, industrial inkjet ink, dyes for textiles and papers, and materials for thermal paper; catalysts to produce acrylic and methacrylic acid; and polarizing films, inorganic polarizers, liquid crystal display components and projector parts, and components for x-ray analysis. Its Pharmaceuticals Business segment offers anti-cancer and cancer-related drugs, biosimilars, generic drugs, interventional radiology products, cardiovascular drugs, bulk drugs and intermediates of pharmaceuticals, and drugs for diagnosing cancer, as well as GlycoMark, a product as a marker of blood sugar control used for diabetes. The company's Safety Systems Business segment provides airbag inflators, micro gas generators for seatbelt pretensioners, and squibs. Its Agrochemicals Business segment offers agricultural insecticides, herbicides, soil fumigants, and insanitary insecticides. The company engages in real estate leasing services. The company was formerly known as Nihon Kayaku Seizou Co., Ltd. and changed its name to Nippon Kayaku Co., Ltd. in 1945. Nippon Kayaku Co., Ltd. was incorporated in 1916 and is headquartered in Tokyo, Japan.

Corporate Governance

Nippon Kayaku Co., Ltd.’s ISS Governance QualityScore as of May 1, 2025 is 5. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 3; Compensation: 1.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 13, 2025 at 7:00 AM UTC

Nippon Kayaku Co., Ltd. Earnings Date

Recent Events

March 28, 2025 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers